Douglas E. Biancur
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer, Hypoxia, and Metabolism 6
- Oncology 5
- Pancreatic and Hepatic Oncology Research 5
- Co-authors
- Alec C. Kimmelman (13 shared papers)Joseph Douglas Mancias (7 shared papers)Xiaoxu Wang (4 shared papers)Albert S.W. Sohn (7 shared papers)Keisuke Yamamoto (5 shared papers)Robert S. Banh (5 shared papers)Elaine Y. Lin (4 shared papers)Cristovão M. Sousa (2 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Nature (3 papers)Cancer Discovery (2 papers)eLife (2 papers)Nature Cancer (1 paper)
- Partner nations
- United StatesFrancePoland
In The Last Decade
Douglas E. Biancur
18 papers receiving 4.1k citations
Douglas E. Biancur's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 1.3k
- Oncology 1.1k
- Immunology 698
- Physiology 156
- Epidemiology 905
Countries citing papers authored by Douglas E. Biancur
This map shows the geographic impact of Douglas E. Biancur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Biancur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Biancur more than expected).
Fields of papers citing papers by Douglas E. Biancur
This network shows the impact of papers produced by Douglas E. Biancur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Biancur. The network helps show where Douglas E. Biancur may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas E. Biancur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I Hit paper breakdown → | 2020 | 980 |
| 2 | Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion Hit paper breakdown → | 2016 | 911 |
| 3 | Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis Hit paper breakdown → | 2015 | 463 |
| 4 | 2017 | 265 | |
| 5 | 2018 | 264 | |
| 6 | 2020 | 217 | |
| 7 | 2017 | 196 | |
| 8 | 2022 | 174 | |
| 9 | 2022 | 127 | |
| 10 | 2018 | 116 | |
| 11 | 2023 | 91 | |
| 12 | 2016 | 78 | |
| 13 | 2021 | 70 | |
| 14 | 2020 | 66 | |
| 15 | 2019 | 49 | |
| 16 | 2021 | 45 | |
| 17 | 2016 | 30 | |
| 18 | 2020 | 5 | |
| 19 | 2020 | 0 | |
| 20 | 2024 | 0 |
About Douglas E. Biancur
Douglas E. Biancur is a scholar working on Cancer Research, Oncology, Epidemiology, Radiation and Immunology, having authored 21 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Autophagy in Disease and Therapy (5 papers), Nanoplatforms for cancer theranostics (4 papers), Epigenetics and DNA Methylation (4 papers), Radiation Therapy and Dosimetry (3 papers), Pancreatic function and diabetes (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.1k citations), Immunology (698 citations), Physiology (156 citations) and Epidemiology (905 citations). Douglas E. Biancur has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Alec C. Kimmelman, Joseph Douglas Mancias, Xiaoxu Wang, Albert S.W. Sohn, Keisuke Yamamoto, Robert S. Banh, Elaine Y. Lin, Cristovão M. Sousa, João A. Paulo and J. Wade Harper. Their work appears in journals such as Journal of Controlled Release, Nature, Cancer Discovery, eLife and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.